Geroscience and the trans-NIH Geroscience Interest Group, GSIG
- PMID: 28299635
- PMCID: PMC5352582
- DOI: 10.1007/s11357-016-9954-6
Geroscience and the trans-NIH Geroscience Interest Group, GSIG
Abstract
Age is by far the major risk factor for most chronic diseases. This has been common knowledge since time immemorial. Aging encompasses the biological changes most often seen as declines of function and increasing burden of disease. The close linkage of these two has led people to believe that aging, like age, is immutable. It is only recently that research into the basic molecular and cellular mechanisms of aging has led to potential interventions that increase lifespan and appear to increase healthspan, as well. Geroscience is an interdisciplinary field that aims to understand the relationship between the biology of aging and the biology of age-related diseases. The "geroscience hypothesis" posits that manipulation of aging will delay (in parallel) the appearance or severity of many chronic diseases because these diseases share the same underlying major risk factor (age). The hope is that this will lead to health improvements in the older population with perhaps greater efficiency than can be achieved through the successful cure and management of diseases of aging as they arise individually or as comorbidities.With those concepts in mind, the Geroscience Interest Group (GSIG) was launched as a trans-institute interest group within the NIH in November 2012. Here, we discuss the genesis of the trans-NIH group and the most salient activities that have occurred in the last 5 years.
Keywords: Aging; Geroscience; Healthspan; Longevity.
Similar articles
-
Moving Geroscience Into Uncharted Waters.J Gerontol A Biol Sci Med Sci. 2016 Nov;71(11):1385-1387. doi: 10.1093/gerona/glw087. Epub 2016 Aug 16. J Gerontol A Biol Sci Med Sci. 2016. PMID: 27535965 No abstract available.
-
Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity.J Physiol. 2016 Apr 15;594(8):2001-24. doi: 10.1113/jphysiol.2014.282665. Epub 2015 Mar 11. J Physiol. 2016. PMID: 25639909 Free PMC article. Review.
-
Advances in geroscience: impact on healthspan and chronic disease.J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1(Suppl 1):S1-3. doi: 10.1093/gerona/glu041. J Gerontol A Biol Sci Med Sci. 2014. PMID: 24833579 Free PMC article. Review.
-
Implementation of longevity-promoting supplements and medications in public health practice: achievements, challenges and future perspectives.J Transl Med. 2017 Jul 20;15(1):160. doi: 10.1186/s12967-017-1259-8. J Transl Med. 2017. PMID: 28728596 Free PMC article. Review.
-
Advances and challenges in geroscience research: An update.Physiol Int. 2018 Dec 1;105(4):298-308. doi: 10.1556/2060.105.2018.4.32. Physiol Int. 2018. PMID: 30587027 Free PMC article. Review.
Cited by
-
Biological and Physical Performance Markers for Early Detection of Cognitive Impairment in Older Adults.J Clin Med. 2024 Jan 30;13(3):806. doi: 10.3390/jcm13030806. J Clin Med. 2024. PMID: 38337499 Free PMC article. Review.
-
Development and Validation of 2 Composite Aging Measures Using Routine Clinical Biomarkers in the Chinese Population: Analyses From 2 Prospective Cohort Studies.J Gerontol A Biol Sci Med Sci. 2021 Aug 13;76(9):1627-1632. doi: 10.1093/gerona/glaa238. J Gerontol A Biol Sci Med Sci. 2021. PMID: 32946548 Free PMC article.
-
Local senolysis in aged mice only partially replicates the benefits of systemic senolysis.J Clin Invest. 2023 Apr 17;133(8):e162519. doi: 10.1172/JCI162519. J Clin Invest. 2023. PMID: 36809340 Free PMC article.
-
Is Testosterone Replacement Therapy in Older Men Effective and Safe?Drugs Aging. 2019 Nov;36(11):981-989. doi: 10.1007/s40266-019-00716-2. Drugs Aging. 2019. PMID: 31595418 Free PMC article. Review.
-
We need to shift the focus of aging research to aging itself.Proc Natl Acad Sci U S A. 2023 Sep 12;120(37):e2307449120. doi: 10.1073/pnas.2307449120. Epub 2023 Sep 8. Proc Natl Acad Sci U S A. 2023. PMID: 37682890 Free PMC article. No abstract available.
References
-
- Bouchlaka MN, Sckisel GD, Chen M, Mirsoian A, Zamora AE, Maverakis E, Wilkins DE, Alderson KL, Hsiao HH, Weiss JM, Monjazeb AM, Hesdorffer C, Ferrucci L, Longo DL, Blazar BR, Wiltrout RH, Redelman D, Taub DD, Murphy WJ. Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. J Exp Med. 2013;210:2223–2237. doi: 10.1084/jem.20131219. - DOI - PMC - PubMed
-
- Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, MA MB, Cardiovascular health study collaborative research group Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56A:M146–M156. doi: 10.1093/gerona/56.3.M146. - DOI - PubMed
-
- Hodes RJ, Sierra F, Austad SN, Epel E, Neigh GN, Erlandson KM, Schafer MJ, LeBrasseur NK, Wiley C, Campisi J, Sehl ME, Scalia R, Eguchi S, Kasinath BS, Halter JB, Cohen HJ, Demark-Wahnefried W, Ahles TA, Barzilai N, Hurria A, Hunt PW (2016) Disease drivers of aging. Ann N Y Acad Sci 1386(1):45–68. doi:10.1111/nyas.13299 - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical